Effects of an equol-containing supplement on advanced glycation end products, visceral fat and climacteric symptoms in postmenopausal women: A randomized controlled trial.
<h4>Introduction</h4>Equol, an isoflavone derivative whose chemical structure is similar to estrogen, is considered a potentially effective agent for relieving climacteric symptoms, for the prevention of lifestyle-related diseases, and for aging care in postmenopausal women. We investiga...
Guardado en:
Autores principales: | Remi Yoshikata, Khin Zay Yar Myint, Hiroaki Ohta, Yoko Ishigaki |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c64f42a0bce407f93626ae498d70715 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Climacteric the journal of the International Menopause Society.
-
Association between Equol Production Status and Nonalcoholic Steatohepatitis
por: Takemi Akahane, et al.
Publicado: (2021) -
Climacteric syndrome in women with diabetes mellitus
por: Olga Rafael'evna Grigoryan
Publicado: (2013) -
S-Equol mitigates motivational deficits and dysregulation associated with HIV-1
por: Kristen A. McLaurin, et al.
Publicado: (2021) -
Advanced Glycation End-Products in Skeletal Muscle Aging
por: Lucas C. Olson, et al.
Publicado: (2021)